Financial forecasting is vital for assessing the future financial health of any business. For Clinical Research Organisations (CROs), which operate with long-term contracts, this task is particularly challenging. Predicting contract profitability early on is difficult, and the longer the contract, the greater the risk and potential error margin.
CROs face a number of financial risks due to their dependence on patient recruitment, multiple site operations, and strict regulatory requirements. Clinical trials rarely proceed as planned, often leading to delays or modifications that create uncertainty in cash flows. Contractual agreements, which typically include performance-based milestones and payment schedules, further complicate forecasting. Additionally, sponsors may face funding uncertainties from internal sources, external investors, or grants, impacting revenue recognition timing. All these risks impact revenue recognition timing which can have significant repercussions for both forecasting and financial management.
Accurate forecasting for CROs involves predicting revenue streams from both existing trials and potential new projects in the pipeline. A key component of forecasting is ensuring contract terms are understood by all parties and that financial planning accommodates potential changes in milestone achievements. By being flexible, adaptable and having contingency plans in place, CROs can navigate these uncertainties without jeopardising the overall project.
Stakeholder management is also important: balancing optimism and conservatism in forecasts is crucial to manage stakeholder expectations without limiting growth opportunities. Sponsors also need to have confidence that the CRO is managing funds efficiently and adhering to the agreed budget. Regular financial reporting and audits ensure that funds are being used appropriately and that any variances from the budget are promptly addressed. This transparency builds trust, which is essential for a successful long-term CRO-Sponsor partnership.
Internal Data
Historical project data can identify trends and model new opportunities. However, past performance may not always predict future results, especially in a growing CRO with varying project lengths, nature, and scope.
External Data
Market conditions and industry trends must be considered to assess their impact on predictions. Questions to address include:
IT Systems and Programs
Accounting and CRM systems are effective tools to manage key data for existing projects and potential studies. Managed correctly, systems are robust and provide a good audit trail of changes over time. However, they can be less flexible for modelling “what if” scenarios so combining them with Excel, or an Excel integration gives greater opportunity for manipulating that data and adapting quickly in a dynamic business environment.
People and communication
Data becomes worthless if it isn’t updated regularly and in an informed way. Effective communication and collaboration among business development, clinical operations, and finance teams help identify risks and gaps in forecasts. Regularly reviewing forecast accuracy against actual results can enhance future predictions.
The most challenging aspect of financial forecasting in a growing CRO is dealing with uncertainty. However, with careful planning, the right tools, transparent and regular communication, the uncertainty can be mitigated. Accurate financial forecasts that are meaningful to key stakeholders in the business will enable informed decision making and support the planning and management of its projects and company growth.
Author: Anna Norris, Head of Finance at PHARMExcel.
Connect with Anna on LinkedIn
